KORIAN (KORI.PA)

FR0010386334 - Common Stock

7.36  -0.29 (-3.79%)

Fundamental Rating

2

Overall KORI gets a fundamental rating of 2 out of 10. We evaluated KORI against 21 industry peers in the Health Care Providers & Services industry. KORI has a medium profitability rating, but doesn't score so well on its financial health evaluation. KORI is valued expensive and it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

KORI had positive earnings in the past year.
In the past year KORI had a positive cash flow from operations.
Each year in the past 5 years KORI has been profitable.
In the past 5 years KORI always reported a positive cash flow from operatings.

1.2 Ratios

KORI's Return On Assets of 0.15% is on the low side compared to the rest of the industry. KORI is outperformed by 76.19% of its industry peers.
KORI's Return On Equity of 0.62% is on the low side compared to the rest of the industry. KORI is outperformed by 76.19% of its industry peers.
KORI's Return On Invested Capital of 2.43% is on the low side compared to the rest of the industry. KORI is outperformed by 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KORI is below the industry average of 5.91%.
Industry RankSector Rank
ROA 0.15%
ROE 0.62%
ROIC 2.43%
ROA(3y)0.36%
ROA(5y)0.75%
ROE(3y)1.49%
ROE(5y)2.76%
ROIC(3y)2.49%
ROIC(5y)3.01%

1.3 Margins

KORI's Profit Margin of 0.50% is on the low side compared to the rest of the industry. KORI is outperformed by 76.19% of its industry peers.
In the last couple of years the Profit Margin of KORI has declined.
KORI's Operating Margin of 7.54% is fine compared to the rest of the industry. KORI outperforms 76.19% of its industry peers.
In the last couple of years the Operating Margin of KORI has declined.
The Gross Margin of KORI (92.07%) is better than 95.24% of its industry peers.
In the last couple of years the Gross Margin of KORI has remained more or less at the same level.
Industry RankSector Rank
OM 7.54%
PM (TTM) 0.5%
GM 92.07%
OM growth 3Y-8.77%
OM growth 5Y-3.82%
PM growth 3Y-46.1%
PM growth 5Y-37.51%
GM growth 3Y-0.1%
GM growth 5Y0.03%

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KORI is destroying value.
KORI has more shares outstanding than it did 1 year ago.
KORI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, KORI has an improved debt to assets ratio.

2.2 Solvency

KORI has an Altman-Z score of 0.51. This is a bad value and indicates that KORI is not financially healthy and even has some risk of bankruptcy.
KORI has a Altman-Z score of 0.51. This is in the lower half of the industry: KORI underperforms 76.19% of its industry peers.
The Debt to FCF ratio of KORI is 34.46, which is on the high side as it means it would take KORI, 34.46 years of fcf income to pay off all of its debts.
KORI's Debt to FCF ratio of 34.46 is on the low side compared to the rest of the industry. KORI is outperformed by 66.67% of its industry peers.
KORI has a Debt/Equity ratio of 1.96. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.96, KORI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF 34.46
Altman-Z 0.51
ROIC/WACC0.82
WACC2.97%

2.3 Liquidity

A Current Ratio of 0.63 indicates that KORI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.63, KORI is doing worse than 71.43% of the companies in the same industry.
KORI has a Quick Ratio of 0.63. This is a bad value and indicates that KORI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.62, KORI is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.62

3

3. Growth

3.1 Past

The earnings per share for KORI have decreased strongly by -77.10% in the last year.
The earnings per share for KORI have been decreasing by -36.91% on average. This is quite bad
KORI shows a small growth in Revenue. In the last year, the Revenue has grown by 7.27%.
The Revenue has been growing slightly by 7.23% on average over the past years.
EPS 1Y (TTM)-77.1%
EPS 3Y-46.73%
EPS 5Y-36.91%
EPS Q2Q%-85.96%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y7.1%
Revenue growth 5Y7.23%
Sales Q2Q%6.66%

3.2 Future

Based on estimates for the next years, KORI will show a very negative growth in Earnings Per Share. The EPS will decrease by -17.31% on average per year.
The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y-69.88%
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%
EPS Next 5YN/A
Revenue Next Year8.42%
Revenue Next 2Y7.06%
Revenue Next 3Y6.39%
Revenue Next 5Y5%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.74, the valuation of KORI can be described as expensive.
Based on the Price/Earnings ratio, KORI is valued a bit more expensive than the industry average as 76.19% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 24.41, KORI is valued quite expensively.
Based on the Price/Forward Earnings ratio of 24.99, the valuation of KORI can be described as rather expensive.
Based on the Price/Forward Earnings ratio, KORI is valued a bit more expensive than 66.67% of the companies in the same industry.
KORI's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 20.59.
Industry RankSector Rank
PE 38.74
Fwd PE 24.99

4.2 Price Multiples

KORI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. KORI is cheaper than 61.90% of the companies in the same industry.
KORI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KORI is cheaper than 95.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.27
EV/EBITDA 8.71

4.3 Compensation for Growth

KORI's earnings are expected to decrease with -17.31% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.27%, KORI has a reasonable but not impressive dividend return.
KORI's Dividend Yield is rather good when compared to the industry average which is at 2.30. KORI pays more dividend than 80.95% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.30, KORI pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.27%

5.2 History

On average, the dividend of KORI grows each year by 10.51%, which is quite nice.
Dividend Growth(5Y)10.51%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

KORI pays out 262.13% of its income as dividend. This is not a sustainable payout ratio.
KORI's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP262.13%
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%

KORIAN

EPA:KORI (6/19/2023, 7:00:00 PM)

7.36

-0.29 (-3.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap783.53M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.27%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 38.74
Fwd PE 24.99
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 0.62%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.54%
PM (TTM) 0.5%
GM 92.07%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.63
Quick Ratio 0.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-77.1%
EPS 3Y-46.73%
EPS 5Y
EPS Q2Q%
EPS Next Y-69.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.27%
Revenue growth 3Y7.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y